Transthyretin-Related Familial Amyloid Polyneuropathy: Evaluation of CSF Enhancement on Serial T1-Weighted and Fluid-Attenuated Inversion Recovery Images following Intravenous Contrast Administration

References

1. ↵
   Coelho T, Sousa A, Lourenco E, Ramalheira J. A study of 159 Portuguese patients with familial amyloidotic polyneuropathy (FAP) whose parents were both unaffected. J Med Genet 1994;31:293–299

   Abstract/FREE Full Text
2. ↵
   Ando Y, Suhr O. Autonomic dysfunction in familial amyloidotic polyneuropathy (FAP). Amyloid 1998;5:288–300

   PubMedWeb of Science
3. ↵
   Connors LH, Lim A, Prokaeva T, et al. Tabulation of human transthyretin (TTR) variants. Amyloid 2003;10:160–184

   CrossRefPubMedWeb of Science
4. ↵
   Ishihara T, Nagasawa T, Yokota T, et al. Amyloid protein of vessels in leptomeninges, cortices, choroid plexuses, and pituitary glands from patients with systemic amyloidosis. Hum Pathol 1989;20:891–895

   PubMed
5. ↵
   Ushiyama M, Ikeda S, Yanagisawa N. Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy. Acta Neuropathol 1991;81:524–528

   CrossRefPubMed
6. ↵
   Brett M, Persey MR, Reilly MM, et al. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 1999;122:183–190

   Abstract/FREE Full Text
7. ↵
   Horowitz S, Thomas C, Gruener G, et al. MR of leptomeningeal spinal and posterior fossa amyloid. AJNR Am J Neuroradiol 1998;19:900–902

   Abstract
8. ↵
   Herrick MK, DeBruyne K, Horoupian DS, et al. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 1996;47:988–992

   Abstract/FREE Full Text
9. ↵
   Kitajima M, Korogi Y, Yamura M, et al. Familial amyloid polyneuropathy: hypertrophy of ligaments supporting the spinal cord. AJNR Am J Neuroradiol 2004;25:1599–1602

   Abstract/FREE Full Text
10. ↵
    Naul LG, Finkenstaedt M. Extensive cerebrospinal fluid enhancement with gadopentetate dimeglumine in a primitive neuroectodermal tumor. AJNR Am J Neuroradiol 1997;18:1709–1711

    Abstract
11. Sakamoto S, Kitagaki H, Ishii K, et al. Gadolinium enhancement of the cerebrospinal fluid in a patient with meningeal fibrosis and cryptococcal infection. Neuroradiology 1997;39:504–505

    CrossRefPubMed
12. Lev MH, Schaefer PW. Subarachnoid gadolinium enhancement mimicking subarachnoid hemorrhage on FLAIR MR images. AJR Am J Roentgenol 1999;173:1414–1415

    PubMed
13. Dechambre SD, Duprez T, Grandin CB, et al. High signal in cerebrospinal fluid mimicking subarachnoid haemorrhage on FLAIR following acute stroke and intravenous contrast medium. Neuroradiology 2000;42:608–611

    CrossRefPubMed
14. ↵
    Mamourian AC, Hoopes PJ, Lewis LD. Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation. AJNR Am J Neuroradiol 2000;21:105–111

    Abstract/FREE Full Text
15. Rai AT, Hogg JP. Persistence of gadolinium in CSF: a diagnostic pitfall in patients with end-stage renal disease. AJNR Am J Neuroradiol 2001;22:1357–1361

    Abstract/FREE Full Text
16. ↵
    Bozzao A, Floris R, Fasoli F, et al. Cerebrospinal fluid changes after intravenous injection of gadolinium chelate: assessment by FLAIR MR imaging. Eur Radiol 2003;13:592–597

    PubMedWeb of Science
17. ↵
    Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:113–116
18. ↵
    Ando Y, Tanaka Y, Ando E, et al. Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 1995;345:195–196
19. ↵
    Essig M, Knopp MV, Schoenberg SO, et al. Cerebral gliomas and metastases: assessment with contrast-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;210:551–557

    PubMed
20. ↵
    Mathews VP, Caldemeyer KS, Lowe MJ, et al. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology 1999;211:257–263

    PubMed
21. Tsuchiya K, Katase S, Yoshino A. Hachiya J. FLAIR MR imaging for diagnosing intracranial meningeal carcinomatosis. AJR Am J Roentgenol 2001;176:1585–1588

    PubMed
22. ↵
    Griffiths PD, Scoley SC, Romanowski CAJ, et al. Contrast-enhanced fluid-attenuated inversion-recovery imaging for leptomeningeal disease in children. AJNR Am J Neuroradiol 2003;24:719–723

    Abstract/FREE Full Text
23. ↵
    Ikeda SI, Yanagisawa N, Allsop D, Glenner GG. Gerstmann-Straussler-Scheinker disease showing beta-protein type cerebellar and cerebral amyloid angiopathy. Acta Neuropathol (Berl) 1994;88:262–266

    PubMed
24. ↵
    Sakashita N, Ando Y, Jinnouchi K, et al. Familial amyloidotic polyneuropathy (ATTR Val30Met) with widespread cerebral amyloid angiopathy and lethal cerebral hemorrhage. Pathol Int 2001;51:476–480

    CrossRefPubMed
25. ↵
    Hittmair K, Mallek R, Prayer D, et al. Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. AJNR Am J Neuroradiol 1996;17:1555–1565

    Abstract
26. ↵
    Berkowitz BA, Wilson CA, Tofts PS, Peshock RM. Effect of vitreous fluidity on the measurement of blood-retinal barrier permeability using contrast-enhanced MRI. Magn Reson Med 1994;31:61–66

    PubMedWeb of Science
27. ↵
    Kanamalla US, Boyko OB. Gadolinium diffusion into orbital vitreous and aqueous humor, perivascular space, and ventricles in patients with chronic renal disease. AJR Am J Roentgenol 2002;179:1350–1352

    PubMed
28. ↵
    Koga T, Ando E, Hirata A, et al. Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy. Am J Ophthalmol 2003;135:188–193

    CrossRefPubMedWeb of Science
29. ↵
    Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995;40:173–196

    CrossRefPubMedWeb of Science
30. ↵
    Goren H, Steinberg MC, Farboody GH. Familial oculoleptomeningeal amyloidosis. Brain 1980;103:473–495

    FREE Full Text
31. ↵
    Martone RL, Schon EA, Goodman DS, et al. Retinol-binding protein is synthesized in the mammalian eye. Biochem Biophys Res Commun 1988;157:1078–1084

    CrossRefPubMedWeb of Science